Spanish Wilson Disease Registry
NCT06466291 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-06-20
Summary
The main objective and purpose of the Registry is to know the current status of Wilson Disease in Spain.
As secondary objectives, the prevalence and incidence of the disease will be analysed.
Likewise, the analysis aims to define future areas of interest in its pathogenesis, diagnosis, natural history, follow-up, prognosis and treatment.
Improving knowledge at a national level can help to design screening strategies and improve diagnostic circuits.
Conditions
- Wilson Disease
Sponsors & Collaborators
-
Asociación Española para el Estudio del Hígado
lead OTHER
Principal Investigators
-
Zoe Mariño · Asociación Española para el Estudio del Hígado
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-02
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
NCT01695408 ·Status: COMPLETED
-
Hospitalary Chronic Obstructive Pulmonary Disease Registry
NCT02659189 ·Status: UNKNOWN
-
Investigating Idiopathic Pulmonary Fibrosis in Greece
NCT03074149 ·Status: COMPLETED
-
EARCO REGISTRY. History Of Patients With Alpha-1 Antitrypsin
NCT04180319 ·Status: UNKNOWN
-
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
NCT02852928 ·Status: RECRUITING
-
Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema
NCT00700934 ·Status: UNKNOWN
-
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
NCT02951416 ·Status: ACTIVE_NOT_RECRUITING
-
The PROspective German NOn-CF bronchiectaSIS Patient Registry
NCT02574143 ·Status: UNKNOWN
-
Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry
NCT01576068 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
NCT00904384 ·Status: COMPLETED
-
Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
NCT01423071 ·Status: COMPLETED
-
Outcome After Treatment of Pulmonary Aspergilloma
NCT01958710 ·Status: UNKNOWN
-
Interstitial Lung Disease Registry Construction
NCT03238989 ·Status: UNKNOWN
-
Longitudinal Pathogen-colonization in Cystic Fibrosis Airways and Ability to Smell
NCT00803881 ·Status: UNKNOWN
-
Co-morbidity and Refractory Asthma - UK Severe Asthma Registry
NCT04553276 ·Status: UNKNOWN
-
Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care
NCT01516528 ·Status: COMPLETED
-
In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients
NCT02556697 ·Status: TERMINATED ·Phase: NA
-
Prevalence of Respiratory Aspiration in Patients With COPD
NCT02722629 ·Status: UNKNOWN ·Phase: NA
-
Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPD
NCT05826613 ·Status: UNKNOWN
-
Screening for Lung Health by a Mobile Device
NCT06232356 ·Status: RECRUITING
-
Turkish Thoracic Society Usual Interstitial Pneumonia Registry Study
NCT02821039 ·Status: TERMINATED
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Registry for Chronic Obstructive Pulmonary Disease With Sleep Apnea Hypopnea Syndrome in China
NCT03182309 ·Status: UNKNOWN
-
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
NCT02632123 ·Status: COMPLETED
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED